Community
CVS stops selling certain heartburn medications due to possible cancer risk
CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice according to a press release. This action is being taken out of an abundance of caution due to a recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level of nitrosodimethylamine (NDMA), which is a probable human carcinogen.
The FDA is continuing to evaluate whether low levels of NDMA in ranitidine pose a risk to patients. The levels that FDA is finding in ranitidine from preliminary tests barely exceed amounts found in common foods.
Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time. However, customers who purchased these products can return them to CVS for a refund.
Ranitidine is an H2 Blocker that is taken to provide heartburn relief. CVS Pharmacy will continue to sell other over-the-counter H2 Blockers, including Pepcid, Tagamet and its respective generic equivalents, famotidine and cimetidine.
Consumers seeking alternate therapy to treat their condition should speak with their healthcare provider.
-
Community6 years agoNational Shrine of La Salette Festival of Lights 2017 set to begin
-
Community6 years agoMassachusetts State Police looking for good home for retired dogs
-
Crime6 years agoFall River ranked most dangerous city in Massachusetts according to report
-
latest6 years agoDurfee student allegedly overdoses on marijuana
-
Community6 years agoVideo of Fall River Police goes viral
-
Causes6 years agoMissing Fall River woman found deceased
-
Crime6 years agoFall River Police add names to most wanted list
-
Causes6 years agoFall River teenager reported missing has been found